InvaGen Pharmaceuticals, Inc., 10% Owner at AVENUE THERAPEUTICS, INC. (ATXI), sold 777,776 shares at $7.71 ($6.0M) on 2022-10-11, disclosed to the SEC on 2022-10-13.
Open-market sale of $6.0M ATXI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.71 | 388,888 | $3.0M | 50.0% |
| 2 | $7.71 | 388,888 | $3.0M | 50.0% |
| Total | $7.71 avg | 777,776 | $6.0M | 100% |